The effect of Platelet Lysate on osteoblast proliferation associated witha transient increase of the inflammatory response in bone regeneration

Biomaterials

Volumn 34, Issue 37, 2013, Pages 9318-9330

  Ruggiu, Alessandra ^a,b   Ulivi, Valentina ^a,b   Sanguineti, Francesca ^a,b   Cancedda, Ranieri ^a,b   Descalzi, Fiorella ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Fracture repair; Inflammation; Osteoblasts; Platelet Lysate; Proliferation

Indexed keywords

FRACTURE REPAIR; INFLAMMATION; INFLAMMATORY RESPONSE; OSTEOBLAST PROLIFERATION; PLATELET LYSATE; PRO-INFLAMMATORY CYTOKINES; PROLIFERATION; REGENERATIVE MEDICINE;

CYTOLOGY; MORPHOLOGY; PLATELETS; REPAIR; TISSUE REGENERATION;

OSTEOBLASTS;

CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; PROSTAGLANDIN E2;

ADULT; ARTICLE; BONE REGENERATION; BONE REMODELING; CELL COUNT; CELL CYCLE; CELL DENSITY; CELL DIFFERENTIATION; CELL LYSATE; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE RELEASE; EXTRAVASATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; OSTEOBLAST; PLATELET LYSATE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE RICH PLASMA; UPREGULATION;

FRACTURE REPAIR; INFLAMMATION; OSTEOBLASTS; PLATELET LYSATE; PROLIFERATION;

AGED; AGED, 80 AND OVER; BLOOD PLATELETS; BONE REGENERATION; CELL DIFFERENTIATION; CELL EXTRACTS; CELL PROLIFERATION; CELLS, CULTURED; CYCLOOXYGENASE 2; CYTOKINES; HUMANS; INFLAMMATION; MIDDLE AGED; NF-KAPPA B; OSTEOBLASTS; SIGNAL TRANSDUCTION;

EID: 84884790698     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.08.018     Document Type: Article

References (67)

1. Tortelli F., Cancedda R. Three-dimensional cultures of osteogenic and chondrogenic cells: a tissue engineering approach to mimic bone and cartilage invitro. Eur Cell Mater 2009, 17:1-14.
2. Tortelli F., Pujic N., Liu Y., Laroche N., Vico L., Cancedda R. Osteoblast and osteoclast differentiation in an invitro three-dimensional model of bone. Tissue Eng Part A 2009, 15(9):2373-2383.
3. Tortelli F., Tasso R., Loiacono F., Cancedda R. The development of tissue-engineered bone of different origin through endochondral and intramembranous ossification following the implantation of mesenchymal stem cells and osteoblasts in a murine model. Biomaterials 2010, 31(2):242-249.
4. Tasso R., Fais F., Reverberi D., Tortelli F., Cancedda R. The recruitment of two consecutive and different waves of host stem/progenitor cells during the development of tissue-engineered bone in a murine model. Biomaterials 2010, 31(8):2121-2129.
5. Ruggiu A., Tortelli F., Komlev V.S., Peyrin F., Cancedda R. Extracellular matrix deposition and scaffold biodegradation in an invitro three-dimensional model of bone by X-ray computed microtomography. JTissue Eng Regen Med 2012, Available from URL:. http://www.ncbi.nlm.nih.gov/pubmed/?term=22730262, 10.1002/term.1559.
6. Shahabipour F., Mahdavi-Shahri N., Matin M.M., Tavassoli A., Zebarjad S.M. Scaffolds derived from cancellous bovine bone support mesenchymal stem cells' maintenance and growth. InVitro Cell Dev Biol Anim 2013, 49(6):440-448.
7. Gomez S., Vlad M.D., Lopez J., Navarro M., Fernandez E. Characterization and three-dimensional reconstruction of synthetic bone model foams. Mater Sci Eng C Mater Biol Appl 2013, 33(6):3329-3335.
8. Helmrich U., Di Maggio N., Guven S., Groppa E., Melly L., Largo R.D., et al. Osteogenic graft vascularization and bone resorption by VEGF-expressing human mesenchymal progenitors. Biomaterials 2013, 34(21):5025-5035.
9. Scotti C., Piccinini E., Takizawa H., Todorov A., Bourgine P., Papadimitropoulos A., et al. Engineering of a functional bone organ through endochondral ossification. Proc Natl Acad Sci U S A 2013, 110(10):3997-4002.
10. Foster T.E., Puskas B.L., Mandelbaum B.R., Gerhardt M.B., Rodeo S.A. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med 2009, 37(11):2259-2272.
11. Nurden A.T., Nurden P., Sanchez M., Andia I., Anitua E. Platelets and wound healing. Front Biosci 2008, 13:3532-3548.
12. Bastian O., Pillay J., Alblas J., Leenen L., Koenderman L., Blokhuis T. Systemic inflammation and fracture healing. JLeukoc Biol 2011, 89(5):669-673.
13. Carter M.J., Fylling C.P., Parnell L.K. Use of platelet rich plasma gel on wound healing: a systematic review and meta-analysis. Eplasty 2011, Available from URL:. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174862/.
14. Taylor D.W., Petrera M., Hendry M., Theodoropoulos J.S. Asystematic review of the use of platelet-rich plasma in sports medicine as a new treatment for tendon and ligament injuries. Clin J Sport Med 2011, 21(4):344-352.
15. Hall M.P., Band P.A., Meislin R.J., Jazrawi L.M., Cardone D.A. Platelet-rich plasma: current concepts and application in sports medicine. JAm Acad Orthop Surg 2009, 17(10):602-608.
16. Harmon K., Drezner J., Rao A. Platelet rich plasma for chronic tendinopathy. Br J Sports Med 2013, Available from URL:. http://bjsm.bmj.com/content/47/9/e2.25.abstract, 10.1136/bjsports-2013-092459.31.
17. Dallari D., Savarino L., Stagni C., Cenni E., Cenacchi A., Fornasari P.M., et al. Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells. JBone Jt Surg Am 2007, 89(11):2413-2420.
18. Savarino L., Cenni E., Tarabusi C., Dallari D., Stagni C., Cenacchi A., et al. Evaluation of bone healing enhancement by lyophilized bone grafts supplemented with platelet gel: a standardized methodology in patients with tibial osteotomy for genu varus. JBiomed Mater Res B Appl Biomater 2006, 76(2):364-372.
19. Magnussen R.A., Flanigan D.C., Pedroza A.D., Heinlein K.A., Kaeding C.C. Platelet rich plasma use in allograft ACL reconstructions: two-year clinical results of a MOON cohort study. Knee 2013, 20(4):277-280.
20. Marx R.E., Carlson E.R., Eichstaedt R.M., Schimmele S.R., Strauss J.E., Georgeff K.R. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998, 85(6):638-646.
21. Pereira R.C., Scaranari M., Benelli R., Strada P., Reis R.L., Cancedda R., et al. Dual effect of platelet lysate on human articular cartilage: a maintenance of chondrogenic potential and a transient proinflammatory activity followed by an inflammation resolution. Tissue Eng Part A 2013, 19(11-12):1476-1488.
22. El Backly R.M., Zaky S.H., Muraglia A., Tonachini L., Brun F., Canciani B., et al. Aplatelet-rich plasma-based membrane as a periosteal substitute with enhanced osteogenic and angiogenic properties: a new concept for bone repair. Tissue Eng Part A 2013, 19(1-2):152-165.
23. Zhu W., Zhu X., Huang G.T., Cheung G.S., Dissanayaka W.L., Zhang C. Regeneration of dental pulp tissue in immature teeth with apical periodontitis using platelet-rich plasma and dental pulp cells. Int Endod J 2013, Available from URL:. http://onlinelibrary.wiley.com/doi/10.1111/iej.12087/full, 10.1111/iej.12087.
24. Malik A., Shaari R., Rahman S.A., Aljuboori M.J. Influence of platelet-rich plasma on dental implants. Osseointegration in well-controlled diabetic patients. Dent Implantol Update 2012, 23(12):89-96.
25. Soffer E., Ouhayoun J.P., Anagnostou F. Fibrin sealants and platelet preparations in bone and periodontal healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003, 95(5):521-528.
26. Kim S.A., Ryu H.W., Lee K.S., Cho J.W. Application of platelet-rich plasma accelerates the wound healing process in acute and chronic ulcers through rapid migration and upregulation of cyclin A and CDK4 in HaCaT cells. Mol Med Rep 2013, 7(2):476-480.
27. Cho J.W., Kim S.A., Lee K.S. Platelet-rich plasma induces increased expression of G1 cell cycle regulators, type I collagen, and matrix metalloproteinase-1 in human skin fibroblasts. Int J Mol Med 2012, 29(1):32-36.
28. Geremicca W., Fonte C., Vecchio S. Blood components for topical use in tissue regeneration: evaluation of corneal lesions treated with platelet lysate and considerations on repair mechanisms. Blood Transfus 2010, 8(2):107-112.
29. Alio J.L., Rodriguez A.E., Martinez L.M., Rio A.L. Autologous fibrin membrane combined with solid platelet-rich plasma in the management of perforated corneal ulcers: a pilot study. JAMA Ophthalmol 2013, 131(6):745-751.
30. Panda A., Jain M., Vanathi M., Velpandian T., Khokhar S., Dada T. Topical autologous platelet-rich plasma eyedrops for acute corneal chemical injury. Cornea 2012, 31(9):989-993.
31. Tanidir S.T., Yuksel N., Altintas O., Yildiz D.K., Sener E., Caglar Y. The effect of subconjunctival platelet-rich plasma on corneal epithelial wound healing. Cornea 2010, 29(6):664-669.
32. Sclafani A.P., Saman M. Platelet-rich fibrin matrix for facial plastic surgery. Facial Plast Surg Clin North Am 2012, 20(2):177-186.
33. Danesh-Meyer M.J., Filstein M.R., Shanaman R. Histological evaluation of sinus augmentation using platelet rich plasma (PRP): a case series. JInt Acad Periodontol 2001, 3(2):48-56.
34. Froum S.J., Wallace S.S., Tarnow D.P., Cho S.C. Effect of platelet-rich plasma on bone growth and osseointegration in human maxillary sinus grafts: three bilateral case reports. Int J Periodontics Restorative Dent 2002, 22(1):45-53.
35. Sanchez A.R., Sheridan P.J., Kupp L.I. Is platelet-rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants 2003, 18(1):93-103.
36. Fennis J.P., Stoelinga P.J., Jansen J.A. Mandibular reconstruction: a clinical and radiographic animal study on the use of autogenous scaffolds and platelet-rich plasma. Int J Oral Maxillofac Surg 2002, 31(3):281-286.
37. Rozman P., Bolta Z. Use of platelet growth factors in treating wounds and soft-tissue injuries. Acta Dermatovenerol Alp Panonica Adriat 2007, 16(4):156-165.
38. Villela D.L., Santos V.L. Evidence on the use of platelet-rich plasma for diabetic ulcer: a systematic review. Growth Factors 2010, 28(2):111-116.
39. Zaky S.H., Ottonello A., Strada P., Cancedda R., Mastrogiacomo M. Platelet lysate favours invitro expansion of human bone marrow stromal cells for bone and cartilage engineering. JTissue Eng Regen Med 2008, 2(8):472-481.
40. Jensen E.D., Gopalakrishnan R., Westendorf J.J. Regulation of gene expression in osteoblasts. Biofactors 2010, 36(1):25-32.
41. Heino T.J., Hentunen T.A. Differentiation of osteoblasts and osteocytes from mesenchymal stem cells. Curr Stem Cell Res Ther 2008, 3(2):131-145.
42. Maniatopoulos C., Sodek J., Melcher A.H. Bone formation invitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res 1988, 254(2):317-330.
43. George J., Kuboki Y., Miyata T. Differentiation of mesenchymal stem cells into osteoblasts on honeycomb collagen scaffolds. Biotechnol Bioeng 2006, 95(3):404-411.
44. Groeneveld E.H., Burger E.H. Bone morphogenetic proteins in human bone regeneration. Eur J Endocrinol 2000, 142(1):9-21.
45. Nakase T., Yoshikawa H. Potential roles of bone morphogenetic proteins (BMPs) in skeletal repair and regeneration. JBone Miner Metab 2006, 24(6):425-433.
46. Luu H.H., Song W.X., Luo X., Manning D., Luo J., Deng Z.L., et al. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. JOrthop Res 2007, 25(5):665-677.
47. Doucet C., Ernou I., Zhang Y., Llense J.R., Begot L., Holy X., et al. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. JCell Physiol 2005, 205(2):228-236.
48. Ulivi V., Tutolo G., Mallein-Gerin F., Daga A., Cancedda R., Cancedda F.D. Acommon pathway in differentiation and inflammation: p38 mediates expression of the acute phase SIP24 iron binding lipocalin in chondrocytes. JCell Physiol 2006, 206(3):728-737.
49. Chen C.J., Kono H., Golenbock D., Reed G., Akira S., Rock K.L. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 2007, 13(7):851-856.
50. Rennekampff H.O., Hansbrough J.F., Kiessig V., Dore C., Sticherling M., Schroder J.M. Bioactive interleukin-8 is expressed in wounds and enhances wound healing. JSurg Res 2000, 93(1):41-54.
51. Harada A., Sekido N., Akahoshi T., Wada T., Mukaida N., Matsushima K. Essential involvement of interleukin-8 (IL-8) in acute inflammation. JLeukoc Biol 1994, 56(5):559-564.
52. Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., DiPietro L.A., Elner V.M., et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992, 258(5089):1798-1801.
53. Yang X., Ricciardi B.F., Hernandez-Soria A., Shi Y., Pleshko Camacho N., Bostrom M.P. Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice. Bone 2007, 41(6):928-936.
54. Cho T.J., Kim J.A., Chung C.Y., Yoo W.J., Gerstenfeld L.C., Einhorn T.A., et al. Expression and role of interleukin-6 in distraction osteogenesis. Calcif Tissue Int 2007, 80(3):192-200.
55. El Backly R., Ulivi V., Tonachini L., Cancedda R., Descalzi F., Mastrogiacomo M. Platelet lysate induces invitro wound healing of human keratinocytes associated with a strong proinflammatory response. Tissue Eng Part A 2011, 17(13-14):1787-1800.
56. Borrelli J., Pape C., Hak D., Hsu J., Lin S., Giannoudis P., et al. Physiological challenges of bone repair. JOrthop Trauma 2012, 26(12):708-711.
57. Mountziaris P.M., Spicer P.P., Kasper F.K., Mikos A.G. Harnessing and modulating inflammation in strategies for bone regeneration. Tissue Eng Part B Rev 2011, 17(6):393-402.
58. Chevallier N., Anagnostou F., Zilber S., Bodivit G., Maurin S., Barrault A., et al. Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate. Biomaterials 2010, 31(2):270-278.
59. Soffer E., Ouhayoun J.P., Dosquet C., Meunier A., Anagnostou F. Effects of platelet lysates on select bone cell functions. Clin Oral Implants Res 2004, 15(5):581-588.
60. Vogel J.P., Szalay K., Geiger F., Kramer M., Richter W., Kasten P. Platelet-rich plasma improves expansion of human mesenchymal stem cells and retains differentiation capacity and invivo bone formation in calcium phosphate ceramics. Platelets 2006, 17(7):462-469.
61. Chambard J.C., Lefloch R., Pouyssegur J., Lenormand P. ERK implication in cell cycle regulation. Biochim Biophys Acta 2007, 1773(8):1299-1310.
62. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129(7):1261-1274.
63. Grundnes O., Reikeras O. The importance of the hematoma for fracture healing in rats. Acta Orthop Scand 1993, 64(3):340-342.
64. Simon A.M., Manigrasso M.B., O'Connor J.P. Cyclo-oxygenase 2 function is essential for bone fracture healing. JBone Miner Res 2002, 17(6):963-976.
65. Zhang X., Schwarz E.M., Young D.A., Puzas J.E., Rosier R.N., O'Keefe R.J. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. JClin Invest 2002, 109(11):1405-1415.
66. Xie C., Liang B., Xue M., Lin A.S., Loiselle A., Schwarz E.M., et al. Rescue of impaired fracture healing in COX-2-/- mice via activation of prostaglandin E2 receptor subtype 4. Am J Pathol 2009, 175(2):772-785.
67. Maggini J., Mirkin G., Bognanni I., Holmberg J., Piazzon I.M., Nepomnaschy I., et al. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One 2010, Available from URL:. http://www.plosone.org/article/info%253Adoi%252F10.1371%252Fjournal.pone.0009252, 10.1371/journal.pone.0009252.